| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | $351.37M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $180.89M | $192.95M | $164.16M | $130.65M | $212.99M |
| R&D | $148.02M | $144.10M | $114.24M | $81.94M | $167.21M |
| SG&A | $32.86M | $48.85M | $49.92M | $48.71M | $45.78M |
| Operating Income | -$180.89M | -$192.95M | -$164.16M | -$130.65M | $138.38M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | -$6.16M | $925.00K | $1.02M | -$3.59M | $17.40M |
| Net Income | -$158.35M | -$168.38M | -$135.96M | -$115.91M | $121.19M |
| EPS (basic) | -1.9400 | -2.0000 | -1.6300 | -1.3900 | 1.4600 |
| EPS (diluted) | -1.9400 | -2.0000 | -1.6300 | -1.3900 | 1.3700 |
| Shares (diluted) | $81.50M | $84.26M | $83.39M | $83.25M | $88.25M |